Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1
- PMID: 24132671
- DOI: 10.1007/s00415-013-7141-6
Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1
Abstract
A wide range of ocular abnormalities have been documented to occur in patients with myotonic dystrophy type 1. The objectives of this study were to investigate the macular and optic nerve morphology using optical coherence tomography in patients with myotonic dystrophy type 1. A total of 30 myotonic dystrophy type 1 patients and 28 controls were recruited for participation. All participants underwent a thorough ophthalmologic examination, including spectral-domain optical coherence tomography of the macula and retinal nerve fibre layer. Images were reviewed by a retinal specialist ophthalmologist, masked to the diagnosis of the participants. Average macular thickness was significantly greater in the myotonic dystrophy group compared to controls [327.3 μm vs. 308.5 μm (p < 0.001)]. Macular thickness was significantly greater (p < 0.005) in five of the nine macular regions. The increase in macular thickness was due to the increased prevalence of epiretinal membranes in the myotonic dystrophy patient group (p = 0.0002): 48.2 % of myotonic dystrophy patient eyes had evidence of epiretinal membrane, compared with 12.5 % of control eyes. Examination revealed that 56.7 % of myotonic dystrophy patients had an epiretinal membrane in at least one eye. Visual acuity was reduced due to the presence of epiretinal membrane in six patient eyes and none of the control eyes. The presence of an epiretinal membrane was significantly correlated with increasing age in the patient group. We report an increased prevalence of epiretinal membrane in the myotonic dystrophy type 1 group. This may be a previously under-recognised form of visual impairment in this group. Epiretinal membranes can be treated surgically. We suggest that, in addition to a comprehensive clinical examination, optical coherence tomography examination is implemented as part of an ophthalmological assessment for the myotonic dystrophy type 1 patient with reduced visual acuity.
Similar articles
-
Spectral domain optical coherence tomography findings in myotonic dystrophy.Neuromuscul Disord. 2020 Feb;30(2):144-150. doi: 10.1016/j.nmd.2019.11.012. Epub 2019 Nov 30. Neuromuscul Disord. 2020. PMID: 32005494
-
[Myelinated nerve fibers coexisted with epiretinal membrane in macula--case report].Klin Oczna. 2012;114(1):41-3. Klin Oczna. 2012. PMID: 22783744 Polish.
-
Thickness of the Macula, Retinal Nerve Fiber Layer, and Ganglion Cell Layer in the Epiretinal Membrane: The Repeatability Study of Optical Coherence Tomography.Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4554-9. doi: 10.1167/iovs.15-16949. Invest Ophthalmol Vis Sci. 2015. PMID: 26200495
-
Optical coherence tomography in imaging of macular diseases.Klin Oczna. 2010;112(4-6):138-46. Klin Oczna. 2010. PMID: 20825070 Review.
-
Spectral-domain optical coherence tomography use in macular diseases: a review.Ophthalmologica. 2010;224(6):333-40. doi: 10.1159/000313814. Epub 2010 May 4. Ophthalmologica. 2010. PMID: 20453539 Review.
Cited by
-
Ophthalmic findings in myotonic dystrophy type 2: a case series.J Neurol. 2016 Dec;263(12):2552-2554. doi: 10.1007/s00415-016-8325-7. Epub 2016 Nov 2. J Neurol. 2016. PMID: 27807619 No abstract available.
-
Retinal Imaging of Infants on Spectral Domain Optical Coherence Tomography.Biomed Res Int. 2015;2015:782420. doi: 10.1155/2015/782420. Epub 2015 Jul 6. Biomed Res Int. 2015. PMID: 26221606 Free PMC article. Review.
-
The New Zealand Neuromuscular Disease Patient Registry; Five Years and a Thousand Patients.J Neuromuscul Dis. 2017;4(3):183-188. doi: 10.3233/JND-170240. J Neuromuscul Dis. 2017. PMID: 28800337 Free PMC article.
-
Syndromic Retinitis Pigmentosa: A Narrative Review.Vision (Basel). 2025 Jan 20;9(1):7. doi: 10.3390/vision9010007. Vision (Basel). 2025. PMID: 39846623 Free PMC article. Review.
-
Ophthalmic manifestations of inherited neurodegenerative disorders.Nat Rev Neurol. 2014 Jun;10(6):349-62. doi: 10.1038/nrneurol.2014.79. Epub 2014 May 20. Nat Rev Neurol. 2014. PMID: 24840976 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources